We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00032396
Recruitment Status : Unknown
Verified December 2002 by Control Delivery Systems.
Recruitment status was:  Active, not recruiting
First Posted : March 22, 2002
Last Update Posted : May 29, 2006
Information provided by:

Study Description
Brief Summary:
A study evaluating Retisert in patients with age-related macular degeneration

Condition or disease Intervention/treatment Phase
Macular Degeneration Drug: Retisert Implant Phase 2

Study Design

Study Type : Interventional  (Clinical Trial)
Primary Purpose: Treatment
Study Start Date : November 2001

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00032396

United States, Massachusetts
Control Delivery Systems, Inc.
Watertown, Massachusetts, United States, 02472
Sponsors and Collaborators
Control Delivery Systems
Bausch & Lomb Incorporated
More Information

Additional Information:
ClinicalTrials.gov Identifier: NCT00032396     History of Changes
Other Study ID Numbers: CDS FL-004
First Posted: March 22, 2002    Key Record Dates
Last Update Posted: May 29, 2006
Last Verified: December 2002

Keywords provided by Control Delivery Systems:
Age-Related Macular Degeneration
Subfoveal Choroidal Neovascularization

Additional relevant MeSH terms:
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases
Fluocinolone Acetonide
Anti-Inflammatory Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs